ARCHIVES

Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

Clinton Proposes Increase For Science And Technology.

February 4, 2000

Pretreatment with Azacitidine Achieves 28-Month Remission

August 30, 2013

Radiation Oncology To Become Crowded, ACR Warns Physicians

December 15, 1995

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

March 14, 1986

NIH RPG Success Rate to Fall Further

June 7, 2013

DePinho Apologizes For Investment Advice: On CNBC He Recommended A Firm He Founded

June 1, 2012